Surgical treatment of stage IB cervical cancer

International Journal of Gynecological Cancer

Volumn 22, Issue 9, 2012, Pages 1597-1603

  Ungár, László ^a   Pálfalvi, László ^a   Tarnai, László ^b   Nechushkina, Valentina ^c   Lintner, Balázs ^a   Novák, Zoltán ^b  

^a Saint Stephen Hospital   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

Author keywords

Adjuvant treatment; Cervical cancer; Pelvic connective tissue clearance; Radical hysterectomy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; COHORT ANALYSIS; COMORBIDITY; DISEASE SEVERITY; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OPERATION DURATION; OVERALL SURVIVAL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PUBLICATION; UTERINE CERVIX CANCER;

ADULT; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84872308459     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182725ecd     Document Type: Article

References (30)

1. Quinn MA, Benedet JL, Odicino F, et al. 26th annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 2006;95:S43-S103.
2. Piver MS, Rutledge F, Smith JP. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol. 1993;44:265-272.
3. Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34:206-211.
4. Höckel M, Horn LC, Manthey N, et al. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol. 2009;10:683-692.
5. Koh WJ, Panwala K, Greer B. Adjuvant therapy for high-risk, early stage cervical cancer. Semin Radiat Oncol. 2000;10:51-60.
6. Ungar L, Palfalvi L. Surgical treatment of lymph node metastases in stage IB cervical cancer: the laterally extended parametrectomy (LEP) procedure. Int J Gynecol Cancer. 2003;13:647-651.
7. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144-1153.
8. Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
9. ACOG Committee on Practice Bulletins. ACOG practice bulletin of clinical management guidelines for obstetrician-gynecologists, no. 35: diagnosis and treatment of cervical carcinomas. Obstet Gynecol. 2002;99:855-866.
10. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol. 1999;73:177-183.
11. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage I/b-II/a cervical cancer. Lancet. 1997;350:535-540.
12. Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3-12.
13. Landoni F, Maneo A, Zapardiel I, et al. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study. Eur J Surg Oncol. 2012;38:203-209.
14. Cibula D, Abu-Rustum NR. Pelvic lymphadenectomy in cervical cancerVsurgical anatomy and proposal for a new classification system. Gynecol Oncol. 2010;116:33-37.
15. Van de Putte G, Lie AK, Vach W, et al. Risk grouping in stage IB squamous cell cervical cancer. Gynecol Oncol. 2005;99:106-112.
16. Rutledge TL, Kamelle SA, Tillmanns TD, et al. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference? Gynecol Oncol. 2004;95:70-76.
17. Marchiolé P, Buénerd A, Benchaib M, et al. Clinical significance of lymphovascular space involvement and lymph node micrometastases in early-stage cervical cancer: a retrospective case-control surgico-pathological study. Gynecol Oncol. 2005;97:727-732.
18. Fyles AW, Pintilie M, Kirkbride P, et al. Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis. Radiother Oncol. 1995;35:107-117.
19. Wang SS, Sherman ME, Silverberg SG, et al. Pathological characteristics of cervical adenocarcinoma in a multicenter US-based study. Gynecol Oncol. 2006;103:541-546.
20. Chernofsky MR, Felix JC, Muderspach LI, et al. Influence of quantity of lymph node vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 2006;100:288-293.
21. Courtney M. Surgery versus chemoradiation as first line therapy for stage IB2 cervical cancer. Abstracts of the 41st annual meeting on women's cancer of the Society of Gynecologic Oncologists. March 10-17, 2010. San Francisco, California, USA. Gynecol Oncol. 2010;116:S2-S169.
22. Pettersson F, Ryberg M, Malker B. Second primary cancer after treatment of invasive carcinoma of the uterine cervix, compared with those arising after treatment for in situ carcinomas. An effect of irradiation? A cancer registry study. Acta Obstet Gynecol Scand. 1990;69:161-174.
23. Kashima K, Yahata T, Fujita K, et al. Analysis of the complications after radical hysterectomy for stage IB, IIA and IIB uterine cervical cancer patients. J Obstet Gynaecol Res. 2010;36:555-559.
24. Güth U, Ella WA, Olaitan A, et al. Total vaginal necrosis: a representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer. Int J Gynecol Cancer. 2010;20:54-60.
25. Covens A, Rosen B, Murphy J, et al. How important is removal of the parametrium at surgery for carcinoma of the cervix? Gynecol Oncol. 2002;84:145-149.
26. Frankman EA, Wang L, Bunker CH, et al. Lower urinary tract injury in women in the United States, 1979-2006. Am J Obstet Gynecol. 2010;202:495.e1-495. e5.
27. Ralph G, Winter R, Michelitsch L, et al. Radicality of parametrial resection and dysfunction of the lower urinary tract after radical hysterectomy. Eur J Gynaecol Oncol. 1991;12:27-30.
28. Averette HE, Nguyen HN, Donato DM, et al. Radical hysterectomy for invasive cervical cancer: a 25-year experience with the Miami technique. Cancer. 1993;71:1422-1437.
29. Cibula D, Velechovska P, Sláma J, et al. Late morbidity following nerve-sparing radical hysterectomy. Gynecol Oncol. 2010;116:506-511.
30. Tarnai L, Ungár L, Pálfalvi L, et al. Femoral artery embolism in patients undergoing a laterally extended parametrectomy (LEP) procedure. Eur J Gynaecol Oncol. 2011;32:401-402.